Rite Aid Corp. (NYSE: RAD) released estimates for its fiscal 2019 full year before the markets opened on Monday. The company now expects to see a net loss per share in the range of $0.04 to flat, down from the previously stated earnings per share of $0.02 to $0.06. The consensus estimates call for $0.03 in EPS and $21.74 billion in revenue for the 2019 fiscal year.
The company also expects to see adjusted EBITDA in a range of $540 million to $590 million, updated from the previously disclosed range of between $615 million and $675 million.
In the release the company stated:
Based upon recent generic drug bid activity and on anticipated generic drug market conditions for the balance of the year, generic drug purchasing efficiencies are expected to be significantly below Rite Aid’s previous experience and will not meet the company’s expectations for the year. The company now expects generic drug purchasing efficiencies to be approximately $80 million less than when Rite Aid established its fiscal 2019 outlook.
Note that the company’s outlook for sales and same-store sales remains unchanged as sales, prescription count growth and pharmacy reimbursement rates continue to be in line with expectations. The expectations for capital expenditures also remain unchanged.
Shares of Rite Aid traded down more than 10% to $1.64 shortly after Monday’s opening bell. The consensus analyst price target is $1.97 and a 52-week trading range is $1.38 to $2.80.
Travel Cards Are Getting Too Good To Ignore (sponsored)
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.